Recently, a new index, C-NLR, which consists of both CRP and neutrophil-to-lymphocyte ratio (NLR), has been proposed, and its prognostic significance was initially validated in patients with pancreatic cancer after pancreatic resection [8]. The gene discussed is CRP; the disease is familial pancreatic carcinoma.